Pfizer has been paying dividends for 35 years and raising them for 14 years. Read more to see whether PFE stock is a buy.

Pfizer (NYSE:PFE) discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the U.S.

BioNTech SE (BNTX) reports a net profit for Q4 2024 amidst a challenging year, with strategic advancements in oncology and ...

We recently published a list of the 10 Safe Dividend Stocks with Yields Above 5%. In this article, we are going to take a ...

Moderna faces challenges with respiratory vaccine sales and strong competition. Click here to read an analysis of MRNA stock ...

With a year-to-date loss of 16.7% as of April 15, the stock is underperforming the S&P 500 Index ($SPX) by a good margin. The ...

Pfizer PFE discovers ... On Feb. 4, the company announced its Q4 2024 earnings, posting adjusted EPS of $0.63, beating the consensus estimate of $0.47, as reported by Benzinga.

Detailed price information for Jazz Pharma Plc (JAZZ-Q) from The Globe and Mail including charting and trades.

Pfizer's stock has suffered a brutal 16.44% drop in April, despite flexing strong Q4 earnings with a 37.2% EPS beat. Over the ...

The Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) has a reputation for being the go-to choice for income-focused investors ...

We recently published a list of 15 Best Large-Cap Value Stocks to Buy as the Recession Hits. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other best ...

Pfizer Inc. (PFE), headquartered in New York ... On Feb. 4, PFE shares closed down more than 1% after reporting its Q4 results. Its adjusted EPS $0.63 beat Wall Street expectations of $0. ...